High-Quality eCOA Implemented Rapidly

The electronic clinical outcome assessment (eCOA) module within the Signant SmartSignals Unified Platform offers versatile usage options. It can operate independently or seamlessly integrate into Signant Biotech's comprehensive, unified platform, which includes electronic data capture (EDC/DDC), randomization and trial supply management (RTSM), eConsent, and TeleVisit.

This gives users the flexibility to opt for a self-service approach, allowing the customization of the solution using in-house teams. Alternatively, you can choose a full-service option, benefitting from the support of our dedicated and experienced project teams. These teams are backed by Signant Biotech's extensive operational, scientific, and regulatory expertise in eCOA, ensuring a well-rounded and proficient service delivery.

Explore the capabilities of this modern, eCOA solution for high-quality site- and home-based data collection by accessing the brochure below.